GeneDx Holdings Corp. Investing Cash Flow
GeneDx Holdings Corp. (WGS) reported Investing Cash Flow of -$22.89 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-03
- GeneDx Holdings Corp. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$5.63M.
- GeneDx Holdings Corp. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$17.25M.
- GeneDx Holdings Corp. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$11.07M.
- GeneDx Holdings Corp. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$4.69M.
- GeneDx Holdings Corp. net cash provided by (used in) investing activities for fiscal 2025 was -$61.52M.
- GeneDx Holdings Corp. net cash provided by (used in) investing activities for fiscal 2024 was -$30.13M.
- GeneDx Holdings Corp. net cash provided by (used in) investing activities for fiscal 2023 was -$43.73M.
- GeneDx Holdings Corp. net cash provided by (used in) investing activities for fiscal 2022 was -$141.33M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$5.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$22.89M 10-Q · filed 2026-08-03 | -$33.96M derived: sum of 3 quarters · filed 2026-08-03 | -$38.64M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$17.25M 10-Q · filed 2026-05-04 | -$28.33M derived: sum of 2 quarters · filed 2026-05-04 | -$33.01M derived: sum of 3 quarters · filed 2026-05-04 | -$69.36M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | -$11.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$15.76M derived: sum of 2 quarters · filed 2026-02-23 | -$52.11M derived: sum of 3 quarters · filed 2026-08-03 | -$61.52M 10-K · filed 2026-02-23 |
| 2025-09-30 | -$4.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$41.04M derived: sum of 2 quarters · filed 2026-08-03 | -$50.45M 10-Q · filed 2025-10-28 | -$50.96M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | -$36.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$45.76M 10-Q · filed 2026-08-03 | -$46.28M derived: sum of 3 quarters · filed 2026-08-03 | -$54.03M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$9.41M 10-Q · filed 2026-05-04 | -$9.93M derived: sum of 2 quarters · filed 2026-05-04 | -$17.68M derived: sum of 3 quarters · filed 2026-05-04 | -$40.38M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$519.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$8.27M derived: sum of 2 quarters · filed 2026-02-23 | -$30.98M derived: sum of 3 quarters · filed 2026-02-23 | -$30.13M 10-K · filed 2026-02-23 |
| 2024-09-30 | -$7.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$30.46M derived: sum of 2 quarters · filed 2025-10-28 | -$29.61M 10-Q · filed 2025-10-28 | -$34.48M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | -$22.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$21.86M 10-Q · filed 2025-07-29 | -$26.72M derived: sum of 3 quarters · filed 2026-02-23 | -$53.85M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $843.00K 10-Q · filed 2025-04-30 | -$4.02M derived: sum of 2 quarters · filed 2026-02-23 | -$31.15M derived: sum of 3 quarters · filed 2026-02-23 | -$42.42M derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | -$4.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$31.99M derived: sum of 2 quarters · filed 2026-02-23 | -$43.26M derived: sum of 3 quarters · filed 2026-02-23 | -$43.73M 10-K · filed 2026-02-23 |
| 2023-09-30 | -$27.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$38.40M derived: sum of 2 quarters · filed 2024-10-29 | -$38.86M 10-Q · filed 2024-10-29 | -$41.70M derived: sum of 4 quarters · filed 2024-10-29 |
| 2023-06-30 | -$11.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | -$11.73M 10-Q · filed 2024-07-30 | -$14.57M derived: sum of 3 quarters · filed 2024-07-30 | -$18.85M derived: sum of 4 quarters · filed 2024-07-30 |
| 2023-03-31 | -$462.00K 10-Q · filed 2024-04-29 | -$3.30M derived: sum of 2 quarters · filed 2024-04-29 | -$7.58M derived: sum of 3 quarters · filed 2024-04-29 | -$137.88M derived: sum of 4 quarters · filed 2024-04-29 |
| 2022-12-31 | -$2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$7.12M derived: sum of 2 quarters · filed 2024-02-23 | -$137.41M derived: sum of 3 quarters · filed 2024-02-23 | -$141.33M 10-K · filed 2024-02-23 |
| 2022-09-30 | -$4.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$134.57M derived: sum of 2 quarters · filed 2023-11-03 | -$138.49M 10-Q · filed 2023-11-03 | -$146.18M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | -$130.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$134.21M 10-Q · filed 2023-08-08 | -$141.90M derived: sum of 3 quarters · filed 2023-08-08 | -$145.52M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$3.91M 10-Q · filed 2023-05-09 | -$11.61M derived: sum of 2 quarters · filed 2023-05-09 | -$15.22M derived: sum of 3 quarters · filed 2023-05-09 | -$19.70M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$7.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$11.31M derived: sum of 2 quarters · filed 2023-03-16 | -$15.79M derived: sum of 3 quarters · filed 2023-03-16 | -$20.79M 10-K · filed 2023-03-16 |
| 2021-09-30 | -$3.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$8.10M derived: sum of 2 quarters · filed 2022-11-14 | -$13.09M 10-Q · filed 2022-11-14 | -$13.09M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$4.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$9.47M 10-Q · filed 2022-08-15 | -$9.47M derived: sum of 3 quarters · filed 2022-08-15 | -$452.23M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$4.99M 10-Q · filed 2022-05-12 | -$4.99M derived: sum of 2 quarters · filed 2022-05-12 | -$447.74M derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $0.00 derived: 10-K/A 6 month − 10-Q 3 month · filed 2021-05-05 | -$442.75M 10-K/A · filed 2021-05-05 | -$31.97M 10-K · filed 2023-03-16 | |
| 2020-09-30 | -$442.75M 10-Q · filed 2020-11-16 | -$20.48M 10-Q · filed 2021-11-15 | ||
| 2019-12-31 | -$15.46M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |